ATF3 and metabolic disease: The beneficial effect of ST32da in ameliorating the metabolic disorder and in reducing the depot weight of iWAT, eWAT, mWAT, rWAT, and BAT was lost in these HFD-fed ATF3−/− mice (Supplementary Fig. 8c–e).